Tag Archives: Approved

What weight loss drugs are fda approved

The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. The two exceptions are Meridia and Xenical. Medications don’t replace physical activity or healthy eating habits as a way to lose weight. Sign up for What weight loss drugs are fda approved’s Health’s new newsletter, So… Read More »

When was carisoprodol approved

Before sharing sensitive information, make sure you’re on a federal government site. Discuss the risks and benefits with your doctor. 657 million for a shorter period. Since the withdrawal of Vioxx it has come to light that there may be negative cardiovascular effects with not only other COX-2 inhibitiors, but even the majority of other… Read More »

‘A new era’: First peanut allergy drug for children, teens approved by U.S. regulators

U.S. health regulators approved the first drug for children and teenagers with peanut allergies, marking a potential paradigm shift in treatment. The drug, which will be sold under the brand name Palforzia, will be marketed by Aimmune Therapeutics Inc.. The therapy involves ingesting small doses of peanut protein, gradually increased over time to help desensitize… Read More »

1st peanut allergy drug for children approved by FDA – NBCNews.com

In a new, groundbreaking development in the fight against food allergies, the Food and Drug Administration approved the first treatment for children with peanut allergies on Friday. “Peanut allergy affects approximately 1 million children in the U.S. and only 1 out of 5 of these children will outgrow their allergy,” said Dr. Peter Marks, director… Read More »

Lynparza (olaparib) Approved in the US as a First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer

Print this page 30 December 2019 — AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) today announced that Lynparza® (olaparib) has been approved in the US for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) metastatic pancreatic adenocarcinoma whose… Read More »

Givlaari Approved for Acute Hepatic Porphyria

News Consumer News Givlaari Approved for Acute Hepatic Porphyria FRIDAY, Nov. 22, 2019 — On Wednesday, the U.S. Food and Drug Administration announced the approval of Givlaari (givosiran) for the treatment of acute hepatic porphyria. Previous treatment options for this genetic disorder have only provided partial relief from the pain of porphyria attacks, according to… Read More »

Novartis slaps $2M-plus price tag on newly approved gene therapy Zolgensma—and cost watchdogs approve

Industry watchers have been speculating for months about just how high Novartis would price gene therapy Zolgensma on approval—and just how payers would cover it. And with the FDA’s green light, they now have an answer. The Swiss drugmaker will roll out the drug, a one-time treatment for pediatric patients less than 2 years of… Read More »